Clinical Trials
for Kidney Disease in District of Columbia
12 clinical trials for Kidney Disease are currently recruiting participants at study sites in District of Columbia. Study-related care is provided at no cost.
Kidney Disease clinical trials in District of Columbia: what to expect
Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.
In District of Columbia, recruiting kidney disease studies are concentrated in Washington D.C.. 6 of the 12 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.
Who kidney disease trials usually look for
Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.
What taking part involves
Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.
Questions worth asking the study team
Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.
Showing 12 of 12 recruiting Kidney Disease trials in District of Columbia
Where the Kidney Disease studies are in District of Columbia
- Research Site, Washington D.C.3 trials
- Children's National Hospital, Washington D.C.2 trials
- Children's National Hospital - Nephrology, Washington D.C.2 trials
- Children's National Medical Center, Washington D.C.1 trial
- Georgetown University, Washington D.C.1 trial
- The George Washington University - GW Medical Faculty Associates, Washington D.C.1 trial
Counts are recruiting studies listing at least one site in District of Columbia, from ClinicalTrials.gov, refreshed every two days.
Kidney Disease clinical trials in District of Columbia: common questions
Check Your Eligibility
Create a free profile and our AI will match you to Kidney Disease trials near you in District of Columbia.
Get Matched — FreeKidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.
All Kidney Disease trials →